Potent Synergistic Interactions between Lopinavir and Azole Antifungal Drugs against Emerging Multidrug-Resistant Candida auris
Hassan E. Eldesouky, Ehab A. Salama, Nadia A. Lanman, Tony R. Hazbun, Mohamed N. Seleem
Abstract
The limited therapeutic options and the recent emergence of multidrug-resistant Candida species present a significant challenge to human medicine and underscore the need for novel therapeutic approaches. Drug repurposing appears as a promising tool to augment the activity of current azole antifungals, especially against multidrug-resistant Candida auris . In this study, we evaluated the fluconazole chemosensitization activities of 1,547 FDA-approved drugs and clinical molecules against azole-resistant C. auris .
Topics & Concepts
Candida aurisAzoleFluconazoleMultiple drug resistancePharmacologyDrugDrug repositioningAntifungalRepurposingAntifungal drugsMedicineDrug resistanceBiologyMicrobiologyEcologyAntifungal resistance and susceptibilityPneumocystis jirovecii pneumonia detection and treatmentSynthesis and Biological Evaluation